"Synergism Of Immunogenicity Via Combined Parenteral And Mucosal Immunization Against Covid-19" in Patent Application Approval Process (USPTO 20240342271).

The patent application by Bharat Biotech International Limited discusses a method for generating a robust immune response against COVID-19 through a combination of parenteral and mucosal immunization. The approach aims to address the limitations of existing COVID-19 vaccines by enhancing mucosal immunity to prevent viral transmission. By administering vaccines through different routes and utilizing various adjuvant formulations, this method seeks to provide broader protection against SARS-CoV-2 infection. The invention highlights the importance of heterologous vaccination strategies in developing effective responses to the evolving COVID-19 pandemic. [Extracted from the article]